7 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
, including clinical holds, fines, injunctions, civil penalties, license revocations, recall, seizure, total or partial suspension of production … of an approval, issuance of a warning letter, product recall, product seizure, suspension of production or distribution, fines, refusals of government
8-K
EX-10.1
MBRX
Moleculin Biotech Inc
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-99.1
qfkxfy
12 Dec 18
Regulation FD Disclosure
5:28pm
8-K
EX-10.1
af6j93u4q9l17 hl
21 Jun 18
Entry into a Material Definitive Agreement
4:36pm
- Prev
- 1
- Next